跳至主要内容
临床试验/ACTRN12605000801617
ACTRN12605000801617招募中4 期

e-Healing (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth), Genous Bio-engineered R stent, Post Marketing Registry. The e-Healing registry is a 5000 patients internet based registry. The stent is used for the treatment of a group of selected patients eligible for balloon angioplasty with symptomatic ischemic heart disease due to de novo and/or restenotic coronary artery lesions. The objective of this registry is to collect post marketing surveillance data on patients receiving at least one Genous Bio-Engineered R stent.

OrbusNeich Medical Pty Ltd.0 个研究点目标入组 5,000 人开始时间: 2005年12月21日最近更新:
适应症

试验速览

阶段
4 期
状态
招募中
发起方
入组人数
5,000

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
ot stated 至 ot stated(—)
性别
All

入选标准

  • A group of selected patients eligible for balloon angioplasty with symptomatic ischemic heart disease due to de novo and/or restenotic coronary artery lesions. The Genous stent is suitable for treatment of atherosclerotic or restenotic lesions with a length less than the nominal stent length in coronary arteries having reference vessel diameters of the stent expanded diameter following primary inflation.

排除标准

  • Patients who have previously received murine therapeutic antibodies and exhibited sensitization through the production of Human Anti-Murine Antibodies (HAMA).

研究者

发起方
OrbusNeich Medical Pty Ltd.

相似试验